Skip to main content

Closed

BMRN: BioMarin Pharmaceutical Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth-100.0% / yr

Operating margin13.5%

ROIC3.9%

Financially safe

Strong

Debt / equity0.23×

Interest coverage19.1×

Current ratio5.81×

Valuation

Unrated

P/E ratio42.9×

BioMarin Pharmaceutical Inc.

BMRNNASDAQ Global Select·USD·Closed

BioMarin Pharmaceutical Inc.

BMRNNASDAQ·USD·Closed

$60.02

−0.92%

$60.02

−$0.56 (0.92%)

52W Range

63thpctl

Volume

1.11×avg

Mkt Cap

11.60BUSD

P/E

42.9TTM

Div Yield

–ann

52W Range

63thpctl

Volume

1.11×avg

Market Cap

11.60BUSD

P/E Ratio

42.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings